Bank of New York Mellon’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $936K | Sell |
|
|||||
|
2024
Q3 | $1.69M | Sell |
|
|||||
|
2024
Q2 | $959K | Buy |
|
|||||
|
2024
Q1 | $1.5M | Sell |
|
|||||
|
2023
Q4 | $2.95M | Sell |
|
|||||
|
2023
Q3 | $4.42M | Buy |
|
|||||
|
2023
Q2 | $9.43M | Buy |
|
|||||
|
2023
Q1 | $9.97M | Sell |
|
|||||
|
2022
Q4 | $5.77M | Buy |
|
|||||
|
2022
Q3 | $8.35M | Buy |
|
|||||
|
2022
Q2 | $3.58M | Sell |
|
|||||
|
2022
Q1 | $5.35M | Sell |
|
|||||
|
2021
Q4 | $4.51M | Buy |
|
|||||
|
2021
Q3 | $7.54M | Buy |
|
|||||
|
2021
Q2 | $7.43M | Sell |
|
|||||
|
2021
Q1 | $10.5M | Buy |
|
|||||
|
2020
Q4 | $10.1M | Buy |
|
|||||
|
2020
Q3 | $7.88M | Buy |
|
|||||
|
2020
Q2 | $6.82M | Buy |
|
|||||
|
2020
Q1 | $3.88M | Sell |
|
|||||
|
2019
Q4 | $5.32M | Sell |
|
|||||
|
2019
Q3 | $14M | Sell |
|
|||||
|
2019
Q2 | $29.2M | Sell |
|
|||||
|
2019
Q1 | $36.1M | Sell |
|
|||||
|
2018
Q4 | $51.2M | Buy |
|
|||||
|
2018
Q3 | $61.2M | Buy |
|
|||||
|
2018
Q2 | $53.4M | Sell |
|
|||||
|
2018
Q1 | $62M | Sell |
|
|||||
|
2017
Q4 | $76.7M | Buy |
|
|||||
|
2017
Q3 | $55.4M | Sell |
|
|||||
|
2017
Q2 | $54.9M | Buy |
|
|||||
|
2017
Q1 | $37.8M | Sell |
|
|||||
|
2016
Q4 | $40.2M | Buy |
|
|||||
|
2016
Q3 | $31.2M | Sell |
|
|||||
|
2016
Q2 | $28.8M | Buy |
|
|||||
|
2016
Q1 | $34.3M | Sell |
|
|||||
|
2015
Q4 | $68.6M | Buy |
|
|||||
|
2015
Q3 | $56.9M | Buy |
|
|||||
|
2015
Q2 | $58.8M | Buy |
|
|||||
|
2015
Q1 | $24.1M | Buy |
|
|||||
|
2014
Q4 | $17.3M | Buy |
|
|||||
|
2014
Q3 | $1.62M | Sell |
|
|||||
|
2014
Q2 | $3.72M | Buy |
|
|||||
|
2014
Q1 | $576K | Buy |
|